GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » EPS without NRI

Medlive Technology Co (HKSE:02192) EPS without NRI : HK$0.36 (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co EPS without NRI?

Medlive Technology Co's earnings per share without non-recurring items for the six months ended in Dec. 2023 was HK$0.21. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.36.

During the past 12 months, Medlive Technology Co's average earnings per share (NRI) Growth Rate was 103.40% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 35.40% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 60.90% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Medlive Technology Co's EPS without NRI or its related term are showing as below:

HKSE:02192' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 35.4   Med: 48.1   Max: 51.4
Current: 35.4

During the past 6 years, Medlive Technology Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 51.40% per year. The lowest was 35.40% per year. And the median was 48.10% per year.

HKSE:02192's 3-Year EPS without NRI Growth Rate is ranked better than
85.71% of 77 companies
in the Medical Distribution industry
Industry Median: 7.1 vs HKSE:02192: 35.40

Medlive Technology Co's EPS (Diluted) for the six months ended in Dec. 2023 was HK$0.21. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.36.

Medlive Technology Co's EPS (Basic) for the six months ended in Dec. 2023 was HK$0.22. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.37.


Medlive Technology Co EPS without NRI Historical Data

The historical data trend for Medlive Technology Co's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co EPS without NRI Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial 0.05 0.15 0.08 0.18 0.36

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.04 0.14 0.15 0.21

Competitive Comparison of Medlive Technology Co's EPS without NRI

For the Medical Distribution subindustry, Medlive Technology Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medlive Technology Co's PE Ratio without NRI Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's PE Ratio without NRI falls into.



Medlive Technology Co EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medlive Technology Co  (HKSE:02192) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Medlive Technology Co EPS without NRI Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Medlive Technology Co (HKSE:02192) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.
Executives
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
M3, Inc. 2101 Beneficial owner
Sony Group Corporation 2201 Interest of corporation controlled by you
Tian Liping
Zhang Xiaofeng 2101 Beneficial owner
Liu Lingdi 2101 Beneficial owner
Tian Lixin 2101 Beneficial owner
Brown Brothers Harriman & Co. 2502 Approved lending agent
Fidelity Funds 2101 Beneficial owner
Tiantian Co., Limited

Medlive Technology Co (HKSE:02192) Headlines

No Headlines